Get all your news in one place.
100's of premium titles.
One app.
Start reading
Radio France Internationale
Radio France Internationale
National
RFI

Sanofi confirms €16 billion sale of painkiller Doliprane to US investors

The announcement that Sanofi's Doliprane subsidiary is to be sold under the US flag on 11 October 2024 sparked an outcry from politicians across the political spectrum in France. © ARTUR WIDAK / AFP

French pharamceutical giant Sanofi has confirmed plans to sell a controlling stake in its over-the-counter unit to a US investment fund, after employment and investment guarantees relieved political controversy.

According to Sanofi, the sale of a controlling 50 percent stake in Opella to Clayton Dubilier & Rice (CD&R) has valued the maker of France's leading painkiller, Doliprane, at €16 billion.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.